RE: RNS29 Sep 2023 16:10
DTW: 'then in the same breath he caveats his comments with the tired old trope about it being high risk for investors 'because 9 out of 10 cancer treatment trials fail’
Why did you misrepresent that specific part of the interview DTW? He specifically DIDN’t say what you accuse him of. This isn’t perfect transcript but it’s pretty close:
"so you know it’s, it’s, it is to my mind a higher risk company. If you look at like Trinity Delta or Stifel, they put the standard kind 10% success, the 10% chance of success on AVA6000, *I think it’s much higher than that* (*my emphasis) based on the, and you know again, specific drug and the fact that, again the fact that it’s a improvement on the current SOC'… 'but' (continues) early stage, cancer 1 in 2 get it, easy to become emotional etc. "I see it as a great opportunity”.
Then you accuse him of being 'thick as mince’.
I haven’t got time to write more right now or probably read your reply (sorry) but seriously, you just tried to undermine a whole interview that was actually very interesting to listen to, cos it didn’t support your personal view which is probably more skewed.
Or didn't you listen to the interview properly?